According to Reata Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $23.48 M. In 2022 the company made a revenue of $2.21 M a decrease over the years 2021 revenue that were of $11.49 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $23.48 M | 959.61% |
2022 | $2.21 M | -80.71% |
2021 | $11.49 M | 27.4% |
2020 | $9.01 M | -65.99% |
2019 | $26.51 M | -50.52% |
2018 | $53.58 M | 11.51% |
2017 | $48.05 M | -3.61% |
2016 | $49.85 M | -0.92% |
2015 | $50.31 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |